期刊文献+

局部进展期和晚期胃癌化疗的临床应用及进展 被引量:6

Advances of Chemotherapy for Patients with Locally Advanced and Advanced Gastric Cancer
原文传递
导出
摘要 胃癌在全球是癌症患者的重要死因,局部进展期和晚期胃癌患者预后差。(新)辅助化疗或化放疗在局部进展期胃癌治疗中获得广泛认可,姑息化疗仍是晚期胃癌的重要治疗手段。全文基于大量临床研究的证据进行综述,以更深入认识化疗的临床应用和进展,更好地指导胃癌的临床实践策略。 Gastric cancer remains a leading cause of cancer-related mortality worldwide. The prognosis for patients with locally advanced or metastatic disease is poor. A multimodal approach to treatment with (neo) adjuvant chemotherapy or chemoradiotherapy has therefore been accepted to treat locally advanced gastric cancer.Palliative chemotherapy is still major therapy choice for metastatic gastric cancer.A number of clinical trials are ongoing,which seek to directly compare treatment options. This review will browse current evidences and strategies of gastric cancer treatment and hope to provide clarity and guide management in this area.
作者 李孝远 赵林 LI Xiao-yuan;ZHAO Lin(Peking Union Medical College Hospital ,Beijing 100032,China)
机构地区 北京协和医院
出处 《肿瘤学杂志》 CAS 2018年第12期1159-1164,共6页 Journal of Chinese Oncology
基金 中国抗癌协会基金(CORP-143-09) 北京协和医院中青年科研基金(PUMCH-2016-1.13)
关键词 胃肿瘤 晚期 药物疗法 gastric cancer advanced drug therapy
  • 相关文献

参考文献2

二级参考文献13

  • 1Macdonald JS,Smalley SR,Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J].New England Journal of Medicine,2001,(10):725-730. 被引量:1
  • 2Jemal A,Siegel R,Ward E. Cancer statistics[J].CA:A Cancer Journal for Clinicians,2006.106. 被引量:1
  • 3Roukos DH,Kappas AM. Perspectives in the treatment of gastric cancer(review)[J].Oncology,2005,(02):98-107. 被引量:1
  • 4Kozak KR,Moody JS. The survival impact of the intergroup 0116 trial on patients with gastric cancer[J].International Journal of Radiation Oncology,Biology,Physics,2008,(02):517-521. 被引量:1
  • 5Coburn NG,Guller U,Baxter NN. Adjuvant therapy for resected gastric cancer-rapid,yet incomplete adoption following results of intergroup 0116 trial[J].International Journal of Radiation Oncology,Biology,Physics,2008,(04):1073-1080. 被引量:1
  • 6Hartgrink HH,van de Velde CJ. Status of extended lymph node dissection:locoregional control is the only way to survive gastric cancer[J].Journal of Surgical Oncology,2005,(03):153-165. 被引量:1
  • 7Lim DH,Kim DY,Kang MK. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradioterapy.A radiation oncologist's view[J].British Journal of Cancer,2004,(01):11-17. 被引量:1
  • 8Kim S,Lim DH,Lee J. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach[J].International Journal of Radiation Oncology,Biology,Physics,2005,(05):1279-1285. 被引量:1
  • 9Fiorica F,Cartei F,Enea M. The impact of radiotherapy on survival in respectable gastric carcinoma:A meta analysis of literature data[J].Cancer Treatment Reviews,2007,(08):729-740. 被引量:1
  • 10Jansen EP,Saunders MP,Boot H. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer[J].International Journal of Radiation Oncology,Biology,Physics,2007,(03):781-785. 被引量:1

共引文献447

同被引文献80

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部